Prevalence and Predictors of Pap Smear Cervical Epithelial Cell Abnormality among HIV-Positive and Negative Women Attending Gynecological Examination in Cervical Cancer Screening
暂无分享,去创建一个
[1] U. Jeschke,et al. Prevalence of oral HPV infection in cervical HPV positive women and their sexual partners , 2019, Archives of Gynecology and Obstetrics.
[2] C. Meijer,et al. Early detection of CIN3 and cervical cancer during long‐term follow‐up using HPV/Pap smear co‐testing and risk‐adapted follow‐up in a locally organised screening programme , 2014, International journal of cancer.
[3] M. Campagna,et al. Prevalence and Molecular Epidemiology of Human Papillomavirus Infection in Italian Women with Cervical Cytological Abnormalities , 2014, Journal of public health research.
[4] K. Sundström,et al. Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review , 2014, Current opinion in oncology.
[5] F. Buonaguro,et al. Viral and Cellular Biomarkers in the Diagnosis of Cervical Intraepithelial Neoplasia and Cancer , 2013, BioMed research international.
[6] A. Massinde,et al. Prevalence and predictors of Cervical Intraepithelial Neoplasia among HIV infected women at Bugando Medical Centre, Mwanza-Tanzania , 2013, Infectious Agents and Cancer.
[7] Richard D Moore,et al. Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study , 2013, Journal of acquired immune deficiency syndromes.
[8] K. Richter,et al. Age-specific prevalence of cervical human papillomavirus infection and cytological abnormalities in women in Gauteng Province, South Africa. , 2013, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[9] A. Hailu,et al. Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study , 2013, BMC Cancer.
[10] R. Friedman,et al. Recurrence of cervical intraepithelial neoplasia in human immunodeficiency virus-infected women treated by means of electrosurgical excision of the transformation zone (LLETZ) in Rio de Janeiro, Brazil. , 2013, Sao Paulo medical journal = Revista paulista de medicina.
[11] T. Akande,et al. Prevalence and risk factors of cervical cancer among women in an urban community of Kwara State, north central Nigeria. , 2012, Journal of preventive medicine and hygiene.
[12] Suelene B. N. Tavares,et al. Cervical Cytopathology in a Population of HIV-Positive and HIV-Negative Women , 2012, Journal of tropical medicine.
[13] B. Graubard,et al. Prevalence of oral HPV infection in the United States, 2009-2010. , 2012, JAMA.
[14] J. K. Roy,et al. High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: A population-based study , 2012, Journal of Biosciences.
[15] R. Ozercan,et al. Evaluation of cervical cytological abnormalities in Turkish population. , 2012, Indian journal of pathology & microbiology.
[16] E. Unger,et al. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. , 2011, The Journal of infectious diseases.
[17] C. Komoltri,et al. Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study , 2011, BMC infectious diseases.
[18] G. Ergör,et al. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard. , 2011, Asian Pacific journal of cancer prevention : APJCP.
[19] B. AbdullGaffar,et al. The prevalence of abnormal cervical cytology in women with infertility , 2010, Diagnostic cytopathology.
[20] W. Banzhaf,et al. Risk Factors for Cervical Precancer and Cancer in HIV-Infected, HPV-Positive Rwandan Women , 2010, PloS one.
[21] D. Walmer,et al. Prevalence and severity of cervical squamous intraepithelial lesion in a tertiary hospital in northern Tanzania. , 2010, Tanzania journal of health research.
[22] P. Michelow,et al. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa , 2009, Cancer Causes & Control.
[23] R. Biggar,et al. Risk of human papillomavirus-associated cancers among persons with AIDS. , 2009, Journal of the National Cancer Institute.
[24] V. Melo,et al. Cervical intraepithelial neoplasia recurrence after conization in HIV‐positive and HIV‐negative women , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[25] Y. Tettey,et al. Cervical human papillomavirus infection in accra, ghana. , 2009, Ghana medical journal.
[26] S. Batra,et al. Human Papillomavirus Type 16 Variant Analysis of E6, E7, and L1 Genes and Long Control Region in Biopsy Samples from Cervical Cancer Patients in North India , 2008, Journal of Clinical Microbiology.
[27] B. Thiers. American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors , 2008 .
[28] Robert P Fields. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer. , 2008, The New England journal of medicine.
[29] S. Shapiro,et al. Cervical Human Papillomavirus (HPV) Infection in South African Women: Implications for HPV Screening and Vaccine Strategies , 2007, Journal of Clinical Microbiology.
[30] S. Franceschi,et al. Human papillomavirus and HPV vaccines: a review. , 2007, Bulletin of the World Health Organization.
[31] Juana Santos,et al. HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL CANCER: PATHOGENESIS AND EPIDEMIOLOGY , 2007 .
[32] J. Palefsky. CHAPTER 5 HPV infection and HPV‐associated neoplasia in immunocompromised women , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[33] Helen Trottier,et al. The epidemiology of genital human papillomavirus infection. , 2006, Vaccine.
[34] K. Ault. Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract , 2006, Infectious diseases in obstetrics and gynecology.
[35] N. Kiviat,et al. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. , 2006, Journal of the National Cancer Institute.
[36] K. Anastos,et al. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. , 2005, JAMA.
[37] C. Tremblay,et al. Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women. , 2004, The Journal of infectious diseases.
[38] F. X. Bosch,et al. Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. , 2003, Journal of the National Cancer Institute. Monographs.
[39] Diane Solomon,et al. American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer , 2003, Journal of lower genital tract disease.
[40] Mark Sherman,et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. , 2002, JAMA.
[41] K. Shah,et al. Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. , 2002, American journal of obstetrics and gynecology.
[42] M. Kazatchkine,et al. Increased Risk of Cervical Disease Among Human Immunodeficiency Virus–Infected Women With Severe Immunosuppression and High Human Papillomavirus Load , 2000, Obstetrics and gynecology.
[43] T. Rohan,et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. , 1999, The Journal of infectious diseases.
[44] R. Terry. Management of patients with atypical squamous cells of undetermined significance (ASCUS) on Papanicolaou smears , 1996, The Journal of the American Osteopathic Association.